Literature DB >> 19077023

Complementary alternative medicine use in children with type 1 diabetes mellitus in Erzurum, Turkey.

Duygu Arýkan1, Sibel Karaca Sívríkaya, Nermin Olgun.   

Abstract

AIM AND
OBJECTIVE: The aims of this study were: (i) to determine the types of complementary and alternative medicine use among children with type I diabetes mellitus as reported by parents and (ii) to describe sociodemographic and medical factors associated with the use of such treatments in families residing in Eastern Turkey.
BACKGROUND: Type 1 diabetes mellitus is a tremendously challenging and complex disease for children and families to manage. Therefore, the use of complementary and alternative medicines among children with type 1 diabetes is becoming increasingly popular.
DESIGN: Survey.
METHOD: Parents of 100 paediatric patients (who were diagnosed with type 1 diabetes at least 6 months prior to the study) who visited the participating paediatric endocrinology multidisciplinary centres and clinics for diabetes management were included in the study. Data were collected by using a semi-structured questionnaire. Results. Fifty-two per cent of the parents reported the use of one or more complementary alternative medicine therapies. Most such users (59.6%) were using oral herbal preparations; including morus alba (leaves) aloe vera and stinging nettle.
CONCLUSION: Since we found that 78.6% of those using herbals were satisfied with their results and 69.2% were planning to continue use, it is important for healthcare providers to have relevant knowledge about complementary alternative medicine use and learn about its efficacy and effects (positive and adverse) of these treatments. Relevance to clinical practice. Botanical substitute for insulin seems unlikely, but complementary alternative treatments may provide valuable clues for the development of new oral hypoglycaemic agents and simple dietary agents. It is important for healthcare providers to have up-to-date knowledge about the use and effects of complementary alternative medicines in the outpatient clinical care setting.

Entities:  

Mesh:

Year:  2008        PMID: 19077023     DOI: 10.1111/j.1365-2702.2008.02464.x

Source DB:  PubMed          Journal:  J Clin Nurs        ISSN: 0962-1067            Impact factor:   3.036


  9 in total

1.  Complementary and alternative medicine use in children and adolescents with type 1 diabetes.

Authors:  Jean-François Lemay; Aditi Amin; Danièle Pacaud
Journal:  Paediatr Child Health       Date:  2011-10       Impact factor: 2.253

Review 2.  Complementary and alternative medicine in pediatrics in Turkey.

Authors:  Candan Ozturk; Hulya Karatas; Alfred Längler; Tim Schütze; Rebekka Bailey; Tycho Jan Zuzak
Journal:  World J Pediatr       Date:  2014-12-17       Impact factor: 2.764

Review 3.  Medicinal plants in the adjunctive treatment of patients with type-1 diabetes: a systematic review of randomized clinical trials.

Authors:  Farzaneh Barzkar; Hamid Reza Baradaran; Mohammad Ebrahim Khamseh; Roya Vesal Azad; Jalil Koohpayehzadeh; Yousef Moradi
Journal:  J Diabetes Metab Disord       Date:  2020-09-22

4.  Complementary and alternative medicine in children with type 1 diabetes mellitus.

Authors:  Belma Haliloğlu; Pınar Işgüven; Metin Yıldız; Ilknur Arslanoğlu; Müferet Ergüven
Journal:  J Clin Res Pediatr Endocrinol       Date:  2011

5.  Use of herbal medicinal products among children and adolescents in Germany.

Authors:  Yong Du; Ingrid-Katharina Wolf; Wanli Zhuang; Stefanie Bodemann; Werner Knöss; Hildtraud Knopf
Journal:  BMC Complement Altern Med       Date:  2014-07-02       Impact factor: 3.659

6.  The use of complementary medicine in patients with diabetes.

Authors:  Muzaffer Ilhan; Büşra Demir; Sena Yüksel; Serra Aydın Çataklı; Rabia Sevda Yıldız; Ozcan Karaman; Ertuğrul Taşan
Journal:  North Clin Istanb       Date:  2016-05-16

7.  Patterns and Determinants of Complementary and Alternative Medicine Practitioner Use among Adults with Diabetes in Queensland, Australia.

Authors:  Chi-Wai Lui; Jo Dower; Maria Donald; Joseph R Coll
Journal:  Evid Based Complement Alternat Med       Date:  2012-08-07       Impact factor: 2.629

8.  Peril in the market-classification and dosage of species used as anti-diabetics in Lima, Peru.

Authors:  Rainer W Bussmann; Narel Paniagua-Zambrana; Marinoli Rivas Chamorro; Natalia Molina Moreira; María Luisa del Rosario Cuadros Negri; Jose Olivera
Journal:  J Ethnobiol Ethnomed       Date:  2013-05-30       Impact factor: 2.733

Review 9.  Intercultural Usage of Mori Folium: Comparison Review from a Korean Medical Perspective.

Authors:  Byungjin Joh; Eun Sang Jeon; Su Hye Lim; Yu Lee Park; Wansu Park; Han Chae
Journal:  Evid Based Complement Alternat Med       Date:  2015-10-11       Impact factor: 2.629

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.